Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
biote Community
NasdaqGM:BTMD Community
1
Narratives
written by author
0
Comments
on narratives written by author
12
Fair Values set
on narratives written by author
Create a narrative
biote
Popular
Undervalued
Overvalued
Community Investing Ideas
biote
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Sales Force Expansion Will Drive Clinic Onboarding Amid Competitive Concerns
Key Takeaways Sales force expansion, tech upgrades, and vertical integration are expected to boost clinic growth, margins, and long-term revenue sustainability. Growth in dietary supplements and digital channels diversifies earnings and provides greater resilience and recurring profitability.
View narrative
US$6.67
FV
38.5% undervalued
intrinsic discount
10.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
BTMD
BTMD
biote
Your Fair Value
US$
Current Price
US$4.10
86.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-8m
315m
2015
2018
2021
2024
2025
2027
2030
Revenue US$315.2m
Earnings US$33.3m
Advanced
Set Fair Value